Length of Stay and Hospital Costs for Patients Undergoing Allogeneic Stem-Cell Transplantation

Abstract

In patients who undergo allo-HSCT, LOS can be predicted using patient- and transplant-related characteristics as well as post-transplant complications. LOS is also a driver for increased cost, and further efforts are needed to mitigate transplant complications and resource utilization.